Protein that suppresses androgen receptors could improve prostate cancer diagnosis, treatment
AUGUSTA, Ga. A protein that helps regulate expression of androgen receptors could prove a new focal point for staging and treating testosterone-fueled prostate cancer, Medical College of Georgia researchers say. Levels of the protein, βarrestin2, are lower in some prostate cancer cells t...Scientists discover key event in prostate cancer progression
... 24, 2009, issue of the journal Cell , focuses on androgen receptors, molecules located in the nucleus of cel...show that in androgen-independent prostate cancer, androgen receptors are reprogrammed to regulate a group of ... "Some late-phase prostate cancer does not require androgen hormones for tumor growth, but it does require...Acupuncture, Exercise May Ease Polycystic Ovarian Syndrome
...earing age who suffer from a common endocrine disease called polycystic ovarian syndrome (PCOS). Women with the condition have elevated levels of androgen hormones -- including testosterone -- and often develop ovarian cysts, irregular menstrual cycles and infertility. A key feature of the disease is an ...Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
...ues to grow despite current standard of care hormonal (anti-androgen) therapies. CRPC is more invasive and more likely to spread to other organs than androgen dependent prostate cancers. Patients with CRPC have few treatment options and a poor prognosis. About Picoplatin Picoplatin is designe...Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy
... investigate the use of degarelix for intermittent androgen deprivation therapy (IADT) in patients with advanc...rapies. The study will compare IADT to continuous androgen deprivation therapy (ADT) for 14 months with eithe...as measured by PSA suppression. "Intermittent androgen deprivation therapy is a commonly employed treatme...Androstanediol Glucuronide RIA Test
Description:...urement of serum 3alpha-diol G levels may be useful in the clinical evaluation and management of hirsutism and other conditions with excessive adrenal androgen production. References 1. Rittmaster RS. Endocrin Rev 14:121-132, 1993. 2. Dorfman RI & Shipley RA. Androgens. John Wiley and Sons, ...Androstanediol Glucuronide EIA Test
Description:...urement of serum 3alpha-diol G levels may be useful in the clinical evaluation and management of hirsutism and other conditions with excessive adrenal androgen production. References 1. Rittmaster RS. Endocrin Rev 14:121-132, 1993. 2. Dorfman RI & Shipley RA. Androgens. John Wiley and Sons, ...Study reveals a reprogrammed role for the androgen receptor
BOSTONThe androgen receptor a protein ignition switch for prostate cancer cell growth and division is a master of adaptability. When drug therapy deprives the receptor of androgen hormones, thereby halting cell proliferation, the receptor manages to find an alternate growth route. A new study by...3-D research model tackles prostate cancer spread
...prostate removal surgery should have low levels of androgen and the cancer cells should be suppressed. However...e fact that the cancer cells are very sensitive to androgen and even low levels of androgen in the body could promote the growth of these canc...New drug shows promise in treating drug-resistant prostate cancer
...ovel compounds, MDV3100 and RD162, which block the androgen receptor (AR) in CRPC cells, and report results fr...0 was "designed as a very strong antagonist of the androgen receptor to stop the growth of any prostate cancer...n cancer cells begin to increase production of the androgen receptor, Sawyers said. When the level of...New medications show promise in treating drug-resistant prostate cancer
...n cancer cells begin to increase production of the androgen receptor, said Sawyers. When the level of androgen receptors on the cells' surface reaches a certain ...ny scientists have questioned whether blocking the androgen receptor is a wise course of action. But Sawyers a...HWI scientist first in world to unravel structure of key breast cancer target enzyme
... only been on the market a few years and are targeted to inhibit aromatase specifically. But because the structure was not known, nor the mechanism of androgen to estrogen conversion, the AIs currently in use have been developed using trial and error methods resulting in greater vulnerability to contraindicat...Why the 'perfect' body isn't always perfect
...cludes testosterone, increase waist-to-hip ratios in women by increasing visceral fat, which is carried around the waist. But on the upside, increased androgen levels are also associated with increased strength, stamina, and competitiveness. Cortisol, a hormone that helps the body deal with stressful situatio...Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009
... novel cancer drug candidates from Santaris Pharma and Enzon has announced the targets for four of these compounds: Her3, beta catenin, PIK3CA and the androgen receptor. Pipeline Summary In H1 2009 Santaris Pharma continued the progress for both the drug discovery programs and the drug developme...Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Casodex(R) Tablets
...US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for generic Casodex(R) tablets. Bicalutamide tablets are an androgen receptor inhibitor indicated for use in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analog for the treatment of Stage D2 m...New Report Just Published: World Prostate Cancer Therapeutics Market Report
...apy (IMRT) II-43 Benefits of IMRT II-44 Drawbacks of IMRT II-44 androgen Deprivation Therapy (ADT) II-44 High Dose Radiation (HDR) Monotherapy I...ll Therapeutics Reveals Phase 2 Clinical Trial Results of XYOTAX(TM) in androgen Independent Prostate Cancer Patients II-56 Sanofi-Aventis' Taxotere(R) ...Dendreon Announces Data Presentations and Webcast at AUA Annual Meeting
...April 28, 2009, 2:20 p.m. CDT - "A randomized, double-blind, placebo-controlled, multi-center, phase III trial of sipuleucel-T in men with metastatic, androgen independent prostatic adenocarcinoma (AIPC)." AUA Late-Breaking Science Forum to be held from 1:00 p.m. to 2:30 p.m. CDT. Room W375 at McCormick Pla...Medivation Announces Upcoming Scientific Presentations at Medical Conferences
... April 30, at 11:30 a.m. Pacific Time (Poster Session VIII) About MDV3100 MDV3100 is a novel small-molecule androgen receptor antagonist drug candidate in development for the treatment of castration-resistant (also known as hormone-refractory) prostate cancer (CRPC)....PolarScreen Androgen Receptor Competitor Assay Kit, Red from Molecular Probes (Invitrogen)
Description: The PolarScreen Androgen Receptor (AR) Competitor Assay Kits provide a sensitive and efficient method for studying and screening potential AR ligands using fluorescence polarization (FP). The kits contain rat AR ligand binding domain protein tagged with His and GST [AR-LBD (His-GST)], and a novel, ...